Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RRBI | Common Stock | Award | $13K | +253 | +0.51% | $51.21 | 49.5K | Jan 31, 2024 | Direct | F1 |
holding | RRBI | Common Stock | 48.5K | Jan 31, 2024 | By Self as Trustee of the Jeffrey M. Ashbrook Testamentary Trust |
Id | Content |
---|---|
F1 | This stock was acquired pursuant to the Issuer's Amended and Restated Director Compensation Program in a transaction exempt from Section 16 under Rule 16b-3(d). Under this Program, non-employee directors may elect in advance to receive shares of common stock in lieu of cash director fees payable for their attendance at board meetings, at a price per share equal to the closing sales price of the common stock on the Nasdaq Stock Market on the date of issuance (referred to as the "transaction date"). These shares were issued as payment for the reporting person's board meeting fees for the calendar year ending December 31, 2023. The price as shown above reflects the closing sales price of the common stock on the transaction date. |